News
InvestorsHub on MSN25m
Tempus AI shares climb after FDA approval of heart monitoring softwareTempus AI, Inc. (NASDAQ:TEM) saw its stock rise 3% on Wednesday following the announcement that the company obtained 510(k) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback